This website uses cookies to provide you with the best experience. By using this site you agree to our use of cookies. Please read our cookie notice for more information.

Investor Releases

Date Title View
09 January, 2014 ICON Appoints Dr. Steve Cutler as Chief Operating Officer
24 October, 2013 ICON Reports Third Quarter 2013 Revenue of $340 Million, up 19% Year on Year, EPS of 45C and Raises FY 2013 Guidance.
09 October, 2013 ICON Launches New Patient Safety Service for Real-time Analysis of Aggregated Safety Data
25 July, 2013 ICON Reports second quarter 2013 Revenue of $334 million, up 21% year on year, non-GAAP EPS of 43c and raises FY 2013 Guidance.
23 July, 2013 ICON shareholders vote in favour of all resolutions at its Annual General Meeting
25 April, 2013 ICON Reports First Quarter 2013 Revenue of $317 Million, up 26% year on year and non-GAAP EPS of 36c.
24 April, 2013 ICON Wins ‘Partnership Pioneers of the Year' Award in Recognition of Global Partnership with Pfizer
21 February, 2013 ICON Announces Appointment of Professor William Hall to Board of Directors
19 February, 2013 ICON Reports Fourth Quarter 2012 Revenue of $300 Million, up 24% year on year, EPS of 34c and Full Year revenue of $1.12 billion, EPS of $1.00.
05 February, 2013 ICON Announces the Commencement of Direct Trading on NASDAQ
04 February, 2013 ICON To Acquire Clinical Trial Services Division of Cross Country Healthcare, Inc.
21 December, 2012 Mr. Thomas Lynch Elected as Chairman of ICON plc
18 December, 2012 ICON shareholders vote in favour of all resolutions at its Extraordinary General Meeting relating to the proposed conversion to a direct listing of ICON's shares on NASDAQ
03 December, 2012 ICON plc provides 2013 Financial Guidance ahead of Investor Day in New York
29 November, 2012 Dr. Bruce Given notifies ICON that he will not seek a further term as Chairman of the Board
16 November, 2012 ICON Announces Publication of EGM Circular in Respect of Proposed Conversion to Direct Listing of its Shares on NASDAQ
01 November, 2012 ICON Reports Q3 Revenue of $286 Million, EPS of 29c and Net New Business of $450 Million. (NASDAQ: ICLR) (ISIN:IE0005711209)
05 September, 2012 ICON Forms Strategic Partnership with University College Dublin
24 July, 2012 ICON Reports second quarter 2012 revenue up 19% to $277 million and non-GAAP EPS of 21c (NASDAQ:ICLR) (ISIN:IE0005711209)
20 July, 2012 ICON Shareholders Vote in Favour of All Resolutions at Its Annual General Meeting
Displaying 141 - 160 of 328

Search Investor